subject: UNII:MRL3739G66

subject_name: Dotatate


subject: UNII:MRL3739G66

object_name: pancreatic neuroendocrine tumor G1

tested_intervention: unsure


subject: UNII:MRL3739G66

object_name: Digestive System Neuroendocrine Tumor G2


subject: UNII:MRL3739G66

object_name: Gastrointestinal Carcinoid Tumor


subject: UNII:MRL3739G66

object_name: Metastatic malignant neoplasm to liver

tested_intervention: yes


subject: UNII:MRL3739G66

object_name: Metastatic Digestive System Neuroendocrine Neoplasm


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Labor Pain


subject: UNII:SE2KH7T06F

object_name: lung cancer


subject: UNII:SE2KH7T06F

object_name: lung neoplasm


subject: UNII:SE2KH7T06F

object_name: lung carcinoma


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229

object_name: bladder tumor


subject: UMLS:C2826229

object_name: urinary bladder carcinoma


subject: UMLS:C2826229

object_name: urinary bladder cancer


subject: UMLS:C2826229

object_name: childhood bladder carcinoma


subject: UMLS:C2826229

object_name: malignant urinary system neoplasm


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: vulvodynia


subject: PUBCHEM.COMPOUND:4715169

object_name: Vulvar Vestibulitis


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: UMLS:C2741848

object_name: Duchenne muscular dystrophy


subject: UNII:AIW6036FAS

subject_name: Eteplirsen


subject: UNII:9G6U5L461Q

subject_name: Icotinib

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: opiate dependence


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Small cell lung cancer extensive stage


subject: CHEBI:231679

object_name: small cell lung carcinoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Craving


subject: PUBCHEM.COMPOUND:521372

object_name: Withdrawal from addictive substance; detoxification


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585

object_name: alcohol dependence


subject: CHEBI:39585


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: sarcopenia


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: Hemoglobin SS disease with crisis


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: childhood kidney cell carcinoma


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:72317

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:72317

object_name: Recurrent ovarian cancer


subject: CHEBI:72317

object_name: fallopian tube clear cell adenocarcinoma


subject: CHEBI:72317

object_name: ovarian clear cell adenocarcinoma


subject: UMLS:C4048796

object_name: basal cell carcinoma


subject: UMLS:C4048796

object_name: skin basal cell carcinoma


subject: UMLS:C4048796

object_name: nevoid basal cell carcinoma syndrome


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Cough


subject: PUBCHEM.COMPOUND:9824461

object_name: Cough, CTCAE


subject: PUBCHEM.COMPOUND:9824461

object_name: thyroid tumor


subject: PUBCHEM.COMPOUND:9824461

object_name: thyroid cancer


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: acute pancreatitis


subject: CHEBI:70752

subject_name: Dabigatran


subject: PUBCHEM.COMPOUND:74763996

subject_name: Tebipenem pivoxil

object_name: shigellosis


subject: CHEBI:135799


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: pancreatic neoplasm


subject: UNII:28X28X9OKV

object_name: exocrine pancreatic carcinoma


subject: UNII:28X28X9OKV

object_name: malignant pancreatic neoplasm


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:8988


subject: CHEBI:8988


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: GTOPDB:12790

subject_name: crovalimab

object_name: paroxysmal nocturnal hemoglobinuria


subject: UNII:H9KH1GP3UU

subject_name: CROVALIMAB


subject: UMLS:C5418336


subject: UMLS:C3181238

subject_name: focetria

object_name: Immunocompromised Host


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: Tabagism


subject: CHEBI:27594

subject_name: Graphite

object_name: chronic kidney disease


subject: CHEBI:27594

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C4760648

object_name: colorectal cancer


subject: UMLS:C4760648

object_name: colorectal carcinoma


subject: UMLS:C4760648

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1172402

subject_name: TS-1 titanium silicide


subject: UMLS:C1172402


subject: UMLS:C1172402


subject: UMLS:C2828372


subject: UMLS:C2828372


subject: UMLS:C2828372


subject: UNII:3XVL385Q0M

subject_name: Filgotinib

object_name: rheumatoid arthritis


subject: CHEBI:90943

subject_name: Osimertinib

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:90943

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:73584

subject_name: Leu-Met

object_name: type 2 diabetes mellitus


subject: PR:000015077

subject_name: probable proton-coupled zinc antiporter SLC30A4


subject: UNII:T34SH2H9HI

subject_name: Olorofim

object_name: Invasive fungal infection


subject: CHEBI:135967

subject_name: Casopitant

object_name: major depressive disorder


subject: UMLS:C1831798


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists

object_name: heart failure


subject: UMLS:C0001645

object_name: Heart Failure, CTCAE


subject: UMLS:C0001645

object_name: congestive heart failure


subject: UMLS:C0001645

object_name: heart disorder


subject: UMLS:C0001645

object_name: cardiovascular disorder


subject: CHEBI:49956

subject_name: Xenon

object_name: aortic dissection


subject: CHEBI:49956

object_name: Aortic dissection


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:51450

subject_name: Bosentan


subject: UNII:71492GE1FX

subject_name: Benralizumab

object_name: Chronic obstructive pulmonary disease of horses


subject: UNII:71492GE1FX

object_name: COPD, severe early onset


subject: UNII:71492GE1FX

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:72455102

subject_name: Vorapaxar

object_name: arteriosclerosis disorder


subject: PUBCHEM.COMPOUND:72455102

object_name: atherosclerosis


subject: PUBCHEM.COMPOUND:72455102

object_name: ischemia


subject: PUBCHEM.COMPOUND:72455102

object_name: peripheral vascular disease


subject: PUBCHEM.COMPOUND:72455102

object_name: peripheral arterial disease


subject: PUBCHEM.COMPOUND:72455102

object_name: myocardial infarction


subject: PUBCHEM.COMPOUND:72455102

object_name: Myocardial Infarction, CTCAE


subject: PUBCHEM.COMPOUND:72455102

object_name: Myocardial Infarction by ECG Finding


subject: PUBCHEM.COMPOUND:72455102

object_name: stroke disorder


subject: PUBCHEM.COMPOUND:72455102

object_name: cerebrovascular disorder


subject: CHEBI:145499

subject_name: Donepezil

object_name: Alzheimer disease type 1


subject: CHEBI:15891

subject_name: Taurine

object_name: cataract


subject: CHEBI:15891

object_name: Cataract, CTCAE 3.0


subject: CHEBI:15891

object_name: Cataract, CTCAE 5.0


subject: CHEBI:15891

object_name: cataract on exam (physical finding)


subject: CHEBI:10034

subject_name: warfarin sodium

object_name: Thromboembolism


subject: PUBCHEM.COMPOUND:23083982

subject_name: Elvitegravir

object_name: HIV infection


subject: CHEBI:134703

subject_name: Fluciclovine (18F)

object_name: glioblastoma


subject: CHEBI:134703

object_name: Childhood Glioblastoma


subject: CHEBI:134703

object_name: adult glioblastoma


subject: CHEBI:134703

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:134703

object_name: Recurrent Glioblastoma


subject: CHEBI:134703

object_name: brain glioblastoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: skin melanoma


subject: UNII:UM5219H89V

subject_name: teferrol

object_name: anemia deficiency iron treatment


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: bipolar depression


subject: CHEBI:71219

subject_name: Pazopanib

object_name: renal cell carcinoma


subject: UNII:SFW1D987QV

subject_name: Ferrous bisglycinate

object_name: anemia


subject: UNII:SFW1D987QV

object_name: Anemia, CTCAE


subject: UNII:SFW1D987QV

object_name: Inflammation


subject: UNII:SFW1D987QV

object_name: iron deficiency anemia


subject: UNII:SFW1D987QV

object_name: Intestinal inflammation


subject: UNII:SFW1D987QV

object_name: bowel; complaints


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Small cell lung cancer extensive stage


subject: UNII:28P3DU6DB3

subject_name: Giredestrant

object_name: Childhood Breast Carcinoma


subject: UNII:28P3DU6DB3

object_name: breast carcinoma


subject: UNII:28P3DU6DB3

object_name: breast cancer


subject: CHEBI:33325

subject_name: radium atom

object_name: castration-resistant prostate carcinoma


subject: CHEBI:33325

object_name: Metastatic malignant neoplasm to bone


subject: UMLS:C3827153


subject: UMLS:C3827153


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Heart Failure, CTCAE


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Respiratory Failure, CTCAE


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:10125

subject_name: Zolpidem

object_name: insomnia


subject: CHEBI:10125

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:10125

object_name: Insomnia, CTCAE 5.0


subject: UNII:N658GY6L3E

subject_name: Tebentafusp

object_name: Metastatic Uveal Melanoma


subject: UNII:N658GY6L3E

object_name: Uveal Melanoma Metastatic in the Liver


subject: UMLS:C2986393


subject: UMLS:C2986393


subject: CHEBI:10033

subject_name: Warfarin

object_name: myocardial infarction


subject: CHEBI:10033

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:10033

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:10033

object_name: myocardial ischemia


subject: CHEBI:10033

object_name: Family history of ischemic heart disease


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: rheumatoid arthritis


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:37956

subject_name: histamine antagonist


subject: UMLS:C0740098

subject_name: Antihistamine brand of Diphenhydramine


subject: UMLS:C0019592

subject_name: Histamine H1 Antagonists


subject: UMLS:C3536809

subject_name: Antihistamine [EPC]


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: PUBCHEM.COMPOUND:78162481

subject_name: Lorlatinib

object_name: tumor suppressor gene on chromosome 11


subject: UMLS:C4033631

subject_name: sacubitril / valsartan

object_name: heart failure


subject: UMLS:C4033631


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Mature B-Cell Non-Hodgkin Lymphoma


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:32599

object_name: Premature Labor


subject: CHEBI:6888

object_name: Invagination


subject: CHEBI:6888

object_name: intussusception


subject: CHEBI:5931

subject_name: insulin human

object_name: adult lymphoma


subject: CHEBI:5931

object_name: lymphoma


subject: CHEBI:5931

object_name: pediatric lymphoma


subject: CHEBI:5931

object_name: leukemia


subject: CHEBI:5931

object_name: childhood leukemia


subject: UMLS:C0123677

subject_name: NovoLog


subject: UMLS:C0123677


subject: UMLS:C0123677


subject: UMLS:C0123677


subject: UMLS:C0123677


subject: UMLS:C0876064

subject_name: Lantus


subject: UMLS:C0876064


subject: UMLS:C0876064


subject: UMLS:C0876064


subject: UMLS:C0876064


subject: CHEBI:6801

subject_name: Metformin

object_name: cerebral palsy


subject: PR:000010354

subject_name: tRNA N(3)-cytidine methyltransferase METTL8, mitochondrial

object_name: Non-cystic fibrosis bronchiectasis


subject: UniProtKB:Q8R4E1

subject_name: TIP_RAT T-cell immunomodulatory protein (sprot)


subject: PR:000016362

subject_name: TIP41-like protein


subject: PR:000009123

subject_name: T-cell immunomodulatory protein


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: atherosclerosis


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: UMLS:C0003442

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C0003442

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C1446777

subject_name: Rabbit antigen


subject: UMLS:C1446777


subject: UMLS:C1446777


subject: UMLS:C2093603

subject_name: Rabbit


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:192614

object_name: Fatigue


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: UMLS:C4763757

subject_name: Erfonrilimab

object_name: triple-negative breast carcinoma


subject: UMLS:C4763757

object_name: Triple-Negative Breast Cancer Finding


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: colon adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: rectum adenocarcinoma


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:49668

subject_name: Gefitinib

object_name: Recurrent Rectal Cancer


subject: CHEBI:49668

object_name: Colon cancer recurrent


subject: CHEBI:49668

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:49668

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:49668

object_name: Rectal cancer stage IV


subject: CHEBI:49668

object_name: Stage IV Rectal Cancer AJCC v6


subject: CHEBI:49668

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:49668

object_name: Stage IV Colon Cancer AJCC v6


subject: CHEBI:49668

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:49668

object_name: Malignant neoplasm of colon stage IV


subject: CHEBI:49668


subject: CHEBI:49668

object_name: colon signet ring cell adenocarcinoma


subject: CHEBI:49668

object_name: colon mucinous adenocarcinoma


subject: CHEBI:49668


subject: CHEBI:49668

object_name: rectal signet ring cell adenocarcinoma


subject: CHEBI:49668

object_name: rectum mucinous adenocarcinoma


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: UMLS:C5239502

subject_name: Salovum

object_name: glaucoma


subject: UMLS:C5239502

object_name: Glaucoma, CTCAE


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase

object_name: Lymphoma, Extranodal NK-T-Cell


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: hypertension


subject: CHEBI:73604

object_name: Hypertension, CTCAE


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: shoulder instability anterior


subject: CHEBI:74705

subject_name: Met-Leu

object_name: peritoneal carcinomatosis


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Nocturia


subject: UMLS:C1527137

object_name: Parkinson disease


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:63115

subject_name: Fingolimod

object_name: chronic inflammatory demyelinating polyradiculoneuropathy


subject: CHEBI:74705

object_name: cytokine release syndrome


subject: CHEBI:74705

object_name: Cytokine Release Syndrome, CTCAE


subject: CHEBI:74705

object_name: Pneumonia caused by SARS-CoV-2


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: UNII:1IJV77EI07

subject_name: Tepotinib

object_name: brain neoplasm


subject: CHEBI:90943

subject_name: Osimertinib


subject: CHEBI:3561

subject_name: Cetirizine

object_name: Atopic rhinitis


subject: CHEBI:3561

object_name: Hay fever


subject: CHEBI:50730

subject_name: Montelukast


subject: CHEBI:50730


subject: CHEBI:231683

subject_name: Anakinra

object_name: neurogenic arthropathy


subject: CHEBI:231683

object_name: central nervous system malformation


subject: CHEBI:231683

object_name: congenital nervous system disorder


subject: CHEBI:231683

object_name: papilledema


subject: CHEBI:231683

object_name: Papilledema, CTCAE


subject: CHEBI:231683

object_name: urticaria


subject: CHEBI:231683

object_name: reported urticaria (physical finding)


subject: CHEBI:231683

object_name: Urticaria, CTCAE


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Childhood Central Nervous System Neoplasm


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: UMLS:C5445257

subject_name: Coffeeberry Extract

object_name: mood (physical finding)


subject: UMLS:C5445257

object_name: Brain fog


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: primary biliary cholangitis


subject: UMLS:C1508867

subject_name: MYCOPHENOLIC ACID, ORAL, 180 MG ADMINISTERED

object_name: lupus nephritis


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:94573

subject_name: Zibotentan

object_name: liver cirrhosis


subject: CHEBI:85078

subject_name: Dapagliflozin


subject: CHEBI:44915

subject_name: Propofol

object_name: urinary system disorder


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: graft versus host disease


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:114785

subject_name: Erlotinib

object_name: sclerosing cholangitis


subject: CHEBI:114785

object_name: primary sclerosing cholangitis


subject: CHEBI:114785

object_name: Trisomy 7


subject: CHEBI:16240

subject_name: Hioxyl

object_name: gingivitis


subject: CHEBI:16240

object_name: Gingival bleeding


subject: CHEBI:150712

subject_name: Hyaluronic acid


subject: CHEBI:150712


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: MESH:C000627770

subject_name: folfirinox

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:177451

subject_name: Fasiglifam

object_name: diabetes mellitus


subject: CHEBI:31348

subject_name: Capecitabine

object_name: carcinoma of esophagus


subject: CHEBI:31348

object_name: esophageal cancer


subject: CHEBI:31348

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:31348

object_name: neoplasm of esophagus


subject: UMLS:C0304475

subject_name: Potassium supplement

object_name: Prehypertension


subject: UMLS:C0304475

object_name: hypertension


subject: UMLS:C0304475

object_name: Hypertension, CTCAE


subject: CHEBI:29103


subject: CHEBI:29103


subject: CHEBI:29103


subject: CHEBI:26216

subject_name: potassium atom


subject: CHEBI:26216


subject: CHEBI:26216


subject: UMLS:C3714637

subject_name: Potassium Drug Class


subject: UMLS:C3714637


subject: UMLS:C3714637


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism


subject: UMLS:C3540792


subject: UMLS:C3540792


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: CHEBI:16947


subject: CHEBI:16947


subject: CHEBI:16947


subject: CHEBI:50744

subject_name: citrate salt


subject: CHEBI:50744


subject: CHEBI:50744


subject: MESH:D002951

subject_name: Citrates


subject: MESH:D002951


subject: MESH:D002951


subject: CHEBI:133748

subject_name: citrate anion


subject: CHEBI:133748


subject: CHEBI:133748


subject: CHEBI:30769

subject_name: Citric acid


subject: CHEBI:30769


subject: CHEBI:30769


subject: UMLS:C5203321

subject_name: Exenatide Liquid Injection

object_name: type 2 diabetes mellitus


subject: CHEBI:17234

subject_name: D-glucose

object_name: Hyponatremia


subject: CHEBI:17234

object_name: Hyponatremia, CTCAE


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Hemodynamic stability


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:75722

object_name: Post-Operative Pain


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: multiple sclerosis


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Carcinoma liver resectable


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Childhood Glioblastoma


subject: UNII:DPT0O3T46P

object_name: adult glioblastoma


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Pediatric Disorder


subject: CHEBI:4911

subject_name: Etoposide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934

object_name: adult lymphoma


subject: GTOPDB:4934

object_name: lymphoma


subject: GTOPDB:4934

object_name: pediatric lymphoma


subject: GTOPDB:4934

object_name: leukemia


subject: GTOPDB:4934

object_name: childhood leukemia


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:168396


subject: CHEBI:8764


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:9570

subject_name: Thiotepa


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Unresectable Hepatocellular Carcinoma


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:8364

subject_name: Prazosin

object_name: Scorpion sting


subject: CHEBI:8364

object_name: scorpion envenomation


subject: CHEBI:74705

subject_name: Met-Leu

object_name: iron deficiency anemia


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: IgG4-related retroperitoneal fibrosis


subject: CHEBI:9150

subject_name: Simvastatin

object_name: portal hypertension


subject: CHEBI:9150

object_name: Portal Hypertension, CTCAE


subject: UNII:O6DDV91W1M

subject_name: BEVIRIMAT DIMEGLUMINE

object_name: HIV infection


subject: UMLS:C2698386

subject_name: bevirimat dimeglumine


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: urolithiasis


subject: CHEBI:135946

subject_name: Sincalide

object_name: cholestasis


subject: GTOPDB:12989

subject_name: toripalimab

object_name: small cell carcinoma


subject: GTOPDB:12989

object_name: small cell lung carcinoma


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UNII:GKF8S4C432

subject_name: Anlotinib


subject: UNII:GKF8S4C432


subject: PUBCHEM.COMPOUND:18943906

subject_name: Ibuprofen Ibuprofen Ibuprofen

object_name: Bacterial Infections and Mycoses


subject: PUBCHEM.COMPOUND:18943906

object_name: patent ductus arteriosus


subject: CHEBI:47835

subject_name: levibuprofen


subject: CHEBI:47835


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: skin squamous cell carcinoma


subject: CHEBI:5558

subject_name: Guanfacine

object_name: delirium


subject: CHEBI:5558

object_name: Delirium, CTCAE


subject: CHEBI:6121

subject_name: Ketamine

object_name: pain agnosia


subject: CHEBI:6121

object_name: Pain insensitivity


subject: CHEBI:6121

object_name: Dislocation


subject: CHEBI:6121

object_name: Bone fracture


subject: CHEBI:6121

object_name: Fractured


subject: CHEBI:6121

object_name: abscess


subject: CHEBI:67272

subject_name: Perifosine

object_name: skin melanoma


subject: PUBCHEM.COMPOUND:53395091

object_name: uremia


subject: PUBCHEM.COMPOUND:53395091

object_name: Increased NPN


subject: CHEBI:29950

subject_name: L-cysteine residue


subject: CHEBI:29950


subject: CHEBI:16375

subject_name: D-Cysteine


subject: CHEBI:16375


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:17561


subject: UMLS:C2346794

object_name: diffuse large B-cell lymphoma


subject: UMLS:C2346794

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C2346794

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: pulmonary coin lesion


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:68534

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:68534

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:68534

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:68534

object_name: Prostate Carcinoma Metastatic in the Bone


subject: PR:000017019

subject_name: UBX domain-containing protein 11

object_name: Diabetic foot ulcer


subject: UMLS:C0359156

subject_name: Thymoglobulin

object_name: graft versus host disease


subject: CHEBI:32244

subject_name: Tolperisone hydrochloride

object_name: Low back pain


subject: UMLS:C1564420

subject_name: Tolperisone Hydrochloride


subject: CHEBI:93835

subject_name: Tolperisone


subject: UMLS:C4519113

subject_name: Bacillus calmette-guerin substrain danish 1331 live antigen

object_name: tuberculosis


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: cervical cancer


subject: GTOPDB:9758

object_name: cervical carcinoma


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: CHEBI:37845

subject_name: growth hormone

object_name: liver cirrhosis


subject: CHEBI:37845

object_name: sarcopenia


subject: CHEBI:37845

object_name: growth hormone treatment


subject: CHEBI:37845

object_name: chronic liver failure


subject: CHEBI:37845

object_name: digestive system disorder


subject: CHEBI:37845

object_name: fibrosis


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UNII:NQX9KB6PCL


subject: UNII:NQX9KB6PCL


subject: UNII:NQX9KB6PCL


subject: UNII:NQX9KB6PCL


subject: UNII:NQX9KB6PCL


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: PR:000007968

subject_name: somatotropin


subject: PR:000007968


subject: PR:000007968


subject: PR:000007968


subject: PR:000007968


subject: PR:000007968


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: Memory observations


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: PUBCHEM.COMPOUND:15605151

object_name: secondary hyperparathyroidism


subject: CHEMBL.COMPOUND:CHEMBL3545100


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Childhood Breast Carcinoma


subject: CHEBI:89324

object_name: breast carcinoma


subject: CHEBI:89324

object_name: breast cancer


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3640806

object_name: Refractory Adult Acute Lymphoblastic Leukemia


subject: UMLS:C3640806

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UMLS:C3640806

object_name: Refractory Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:229764

subject_name: Selinexor


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: euthyroid Graves orbitopathy


subject: CHEBI:5801

object_name: endocrine exophthalmos


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: type 1 diabetes mellitus 1


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Hodgkin Disease


subject: PUBCHEM.COMPOUND:596

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:85990

subject_name: Panobinostat


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:85990

object_name: childhood acute myeloid leukemia


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: fallopian tube carcinoma


subject: UNII:68AYS9A614

object_name: fallopian tube cancer


subject: UNII:68AYS9A614

object_name: Ovarian epithelial cancer stage II


subject: UNII:68AYS9A614

object_name: Stage I Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: CHEBI:71013

subject_name: Perampanel

object_name: Parkinson disease


subject: GTOPDB:13791

subject_name: sacituzumab tirumotecan

object_name: cervical cancer


subject: GTOPDB:13791

object_name: cervical carcinoma


subject: UNII:3DV5TD1VL3

subject_name: SACITUZUMAB TIRUMOTECAN


subject: UNII:3DV5TD1VL3


subject: UMLS:C5237963

subject_name: ADC SKB264


subject: UMLS:C5237963


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: Crohn disease


subject: CHEBI:16347

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:16347

object_name: Fatigue


subject: CHEBI:135207

subject_name: Clofedanol

object_name: familial hypercholesterolemia


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:8774

subject_name: Ramipril


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: End stage renal failure on dialysis


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: GTOPDB:6788

subject_name: drotrecogin alfa

object_name: Sepsis


subject: GTOPDB:6788

object_name: Sepsis, CTCAE


subject: UMLS:C1170000


subject: UMLS:C1170000


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C2241157

subject_name: Theophylline ER

object_name: pseudohypoparathyroidism


subject: UMLS:C2241157

object_name: Parathyroid Hormone Resistance


subject: UMLS:C2241157

object_name: pseudohypoparathyroidism type 1A


subject: CHEBI:91400

subject_name: Afatinib

object_name: carcinoma of esophagus


subject: CHEBI:91400

object_name: esophageal cancer


subject: CHEBI:91400

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:91400

object_name: neoplasm of esophagus


subject: CHEBI:91400

object_name: gastroesophageal cancer


subject: CHEBI:91400

object_name: HER2-positive gastric cancer


subject: UMLS:C2697511


subject: CHEBI:3423

subject_name: Carmustine

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:3423

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:3423

object_name: T-cell prolymphocytic leukemia


subject: CHEBI:3423

object_name: B-cell prolymphocytic leukemia


subject: CHEBI:3423

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:3423

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:3423

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:3423

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:3423

object_name: Progression of Multiple Myeloma or Plasma Cell Leukemia


subject: CHEBI:3423

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:3423

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:3423

object_name: plasma cell leukemia


subject: CHEBI:3423

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:3423

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:3423

object_name: Plasma cell myeloma recurrent


subject: CHEBI:3423

object_name: Plasma cell myeloma refractory


subject: CHEBI:3423


subject: CHEBI:3423

object_name: Loss of Chromosome 17p


subject: CHEBI:3423

object_name: chromosome 17p deletion


subject: CHEBI:3423

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:3423

object_name: Hypoploidy


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: T-cell prolymphocytic leukemia


subject: CHEBI:4026

object_name: B-cell prolymphocytic leukemia


subject: CHEBI:4026

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:4026

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:4026

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:4026

object_name: Progression of Multiple Myeloma or Plasma Cell Leukemia


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Chronic lymphocytic leukaemia refractory


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent Chronic Lymphoid Leukemia


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596

object_name: Non-Hodgkin's lymphoma refractory


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: plasma cell leukemia


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Refractory Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:596

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596

object_name: Loss of Chromosome 17p


subject: PUBCHEM.COMPOUND:596

object_name: chromosome 17p deletion


subject: PUBCHEM.COMPOUND:596

object_name: Waldenstrom macroglobulinemia


subject: PUBCHEM.COMPOUND:596

object_name: Hypoploidy


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680

object_name: T-cell prolymphocytic leukemia


subject: CHEBI:28680

object_name: B-cell prolymphocytic leukemia


subject: CHEBI:28680


subject: CHEBI:28680

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:28680

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:28680

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:28680

object_name: Progression of Multiple Myeloma or Plasma Cell Leukemia


subject: CHEBI:28680

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:28680

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:28680

object_name: plasma cell leukemia


subject: CHEBI:28680

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:28680

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:28680

object_name: Plasma cell myeloma recurrent


subject: CHEBI:28680

object_name: Plasma cell myeloma refractory


subject: CHEBI:28680


subject: CHEBI:28680

object_name: Loss of Chromosome 17p


subject: CHEBI:28680

object_name: chromosome 17p deletion


subject: CHEBI:28680

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:28680

object_name: Hypoploidy


subject: CHEBI:4911

subject_name: Etoposide

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:4911

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:4911

object_name: T-cell prolymphocytic leukemia


subject: CHEBI:4911

object_name: B-cell prolymphocytic leukemia


subject: CHEBI:4911

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:4911

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:4911

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:4911

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:4911

object_name: Progression of Multiple Myeloma or Plasma Cell Leukemia


subject: CHEBI:4911

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:4911

object_name: plasma cell leukemia


subject: CHEBI:4911

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:4911

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:4911

object_name: Plasma cell myeloma recurrent


subject: CHEBI:4911

object_name: Plasma cell myeloma refractory


subject: CHEBI:4911


subject: CHEBI:4911

object_name: Loss of Chromosome 17p


subject: CHEBI:4911

object_name: chromosome 17p deletion


subject: CHEBI:4911

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:4911

object_name: Hypoploidy


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: T-cell prolymphocytic leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: B-cell prolymphocytic leukemia


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:82339

subject_name: Merphalan

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:82339

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:82339

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:82339

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:82339

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:82339

object_name: Progression of Multiple Myeloma or Plasma Cell Leukemia


subject: CHEBI:82339

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:82339

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:82339

object_name: plasma cell leukemia


subject: CHEBI:82339

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:82339

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:82339

object_name: Plasma cell myeloma recurrent


subject: CHEBI:82339


subject: CHEBI:82339

object_name: Loss of Chromosome 17p


subject: CHEBI:82339

object_name: chromosome 17p deletion


subject: CHEBI:82339

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:82339

object_name: Hypoploidy


subject: CHEBI:28876

subject_name: Melphalan

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:28876

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:28876

object_name: T-cell prolymphocytic leukemia


subject: CHEBI:28876

object_name: B-cell prolymphocytic leukemia


subject: CHEBI:28876

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:28876

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:28876

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:28876

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:28876

object_name: Progression of Multiple Myeloma or Plasma Cell Leukemia


subject: CHEBI:28876

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:28876

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:28876

object_name: plasma cell leukemia


subject: CHEBI:28876

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:28876

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:28876

object_name: Plasma cell myeloma recurrent


subject: CHEBI:28876


subject: CHEBI:28876

object_name: Loss of Chromosome 17p


subject: CHEBI:28876

object_name: chromosome 17p deletion


subject: CHEBI:28876

object_name: Hypoploidy


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:61057

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:61057

object_name: T-cell prolymphocytic leukemia


subject: CHEBI:61057

object_name: B-cell prolymphocytic leukemia


subject: CHEBI:61057

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:61057

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:61057

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:61057

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:61057

object_name: Progression of Multiple Myeloma or Plasma Cell Leukemia


subject: CHEBI:61057

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:61057

object_name: plasma cell leukemia


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372

object_name: Refractory Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:43689

subject_name: isopentylamine

object_name: HIV-1 infection


subject: UMLS:C0302908

subject_name: Liquid substance

object_name: poliomyelitis


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:1C6V77QF41

object_name: obesity


subject: UNII:1C6V77QF41

object_name: Obesity, CTCAE


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C1120111

object_name: hypertension


subject: UMLS:C1120111

object_name: Hypertension, CTCAE


subject: CHEBI:2549

subject_name: Albuterol

object_name: Sepsis


subject: CHEBI:2549

object_name: Sepsis, CTCAE


subject: CHEBI:2549

object_name: Shock


subject: CHEBI:2549

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:8746

subject_name: Levosalbutamol


subject: CHEBI:8746


subject: CHEBI:8746


subject: CHEBI:8746


subject: CHEBI:8746

object_name: COPD, severe early onset


subject: CHEBI:8746

object_name: chronic obstructive pulmonary disease


subject: CHEMBL.COMPOUND:CHEMBL5314951

subject_name: SONROTOCLAX

object_name: acute myeloid leukemia by FAB classification


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: acute myeloid leukemia


subject: UNII:30R67U9KYS


subject: UNII:30R67U9KYS


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Malignant neoplasm of stomach stage IV


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:49668

subject_name: Gefitinib

object_name: carcinoma of esophagus


subject: CHEBI:49668

object_name: esophageal cancer


subject: CHEBI:49668

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:49668

object_name: neoplasm of esophagus


subject: CHEBI:132922

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:132922

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:132922

object_name: morbid obesity


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:36005

object_name: obesity


subject: CHEBI:36005

object_name: Obesity, CTCAE


subject: CHEBI:36005

object_name: Chronic inflammation


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:39585

subject_name: Carbidopa

object_name: ulcerative colitis


subject: CHEBI:39585

object_name: inflammatory bowel disease 1


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: PUBCHEM.COMPOUND:521372


subject: UMLS:C3827152

object_name: castration-resistant prostate carcinoma


subject: UMLS:C3251836

object_name: endogenous depression


subject: UMLS:C3251836

object_name: major depressive disorder


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:10033


subject: CHEBI:10125

subject_name: Zolpidem

object_name: Shoulder arthritis


subject: CHEBI:10125

object_name: arthroplasty; complications


subject: CHEBI:10125


subject: CHEBI:10125

object_name: Dyssomnias


subject: CHEBI:10125

object_name: Sleep abnormality


subject: CHEBI:10125

object_name: sleep disorder


subject: CHEBI:135914

subject_name: carperitide

object_name: heart failure


subject: CHEBI:135914

object_name: congestive heart failure


subject: CHEBI:135914

object_name: Abnormal left ventricular function


subject: CHEBI:135914

object_name: Heart Decompensation


subject: CHEBI:135914

object_name: cardiomyopathy


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Vertebral compression fracture


subject: CHEBI:46195

object_name: Pain of facet joint


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: CHEBI:77383

subject_name: 1,1-bis(phosphonic acid)


subject: CHEBI:77383


subject: UMLS:C3541401

subject_name: Bisphosphonate drugs affecting bone structure and mineralization


subject: UMLS:C3541401


subject: MESH:D004164

subject_name: Diphosphonates


subject: MESH:D004164


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug


subject: CHEBI:35475


subject: PUBCHEM.COMPOUND:126961754

subject_name: Opioids


subject: PUBCHEM.COMPOUND:126961754


subject: CHEBI:35482

subject_name: opioid analgesic


subject: CHEBI:35482


subject: UMLS:C0242402


subject: UMLS:C0242402


subject: PUBCHEM.COMPOUND:118701161

subject_name: Ecdysterone

object_name: Prediabetes


subject: CHEBI:16587

subject_name: ecdystene


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: adult germ cell tumor


subject: UNII:DPT0O3T46P

object_name: germ cell tumor


subject: UNII:DPT0O3T46P

object_name: childhood germ cell tumor


subject: UNII:DPT0O3T46P

object_name: Germ Cell Cancer


subject: UNII:DPT0O3T46P

object_name: rhabdoid tumor


subject: UNII:DPT0O3T46P

object_name: Childhood Desmoplastic Small Round Cell Tumor


subject: UNII:DPT0O3T46P

object_name: desmoplastic small round cell tumor


subject: UNII:DPT0O3T46P

object_name: Adult Desmoplastic Small Round Cell Tumor


subject: UNII:DPT0O3T46P

object_name: nephroblastoma


subject: UNII:DPT0O3T46P

object_name: Wilms tumor


subject: UNII:DPT0O3T46P

object_name: childhood kidney Wilms tumor


subject: UNII:DPT0O3T46P

object_name: clear cell sarcoma


subject: UNII:DPT0O3T46P

object_name: malignant peripheral nerve sheath tumor


subject: UNII:DPT0O3T46P

object_name: Ewing sarcoma


subject: UNII:DPT0O3T46P

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:DPT0O3T46P

object_name: Adult Soft Tissue Sarcoma


subject: UNII:DPT0O3T46P

object_name: sarcoma


subject: UNII:DPT0O3T46P

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:DPT0O3T46P

object_name: soft tissue sarcoma


subject: UNII:DPT0O3T46P

object_name: Childhood Synovial Sarcoma


subject: UNII:DPT0O3T46P

object_name: Adult Synovial Sarcoma


subject: UNII:DPT0O3T46P

object_name: synovial sarcoma


subject: UNII:DPT0O3T46P

object_name: Adult Rhabdomyosarcoma


subject: UNII:DPT0O3T46P

object_name: rhabdomyosarcoma


subject: UNII:DPT0O3T46P

object_name: Childhood Rhabdomyosarcoma


subject: UNII:DPT0O3T46P

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UNII:DPT0O3T46P

object_name: hepatoblastoma


subject: UNII:DPT0O3T46P

object_name: retinoblastoma


subject: UNII:DPT0O3T46P

object_name: Childhood Neuroblastoma


subject: UNII:DPT0O3T46P

object_name: neuroblastoma


subject: UNII:DPT0O3T46P

object_name: pediatric osteosarcoma


subject: UNII:DPT0O3T46P

object_name: Osteosarcoma


subject: UNII:DPT0O3T46P

object_name: carcinoma


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: liver carcinoma


subject: UMLS:C4086713

object_name: adult Fanconi syndrome


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: lymphoblastic lymphoma


subject: CHEBI:4026

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:4026

object_name: Childhood Lymphoblastic Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4911

subject_name: Etoposide

object_name: lymphoid leukemia


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:63612

subject_name: Nelarabine


subject: CHEBI:63612


subject: CHEBI:63612


subject: CHEBI:63612


subject: CHEBI:63612


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:92043599

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:92043599

object_name: Chronic uremia


subject: MESH:C000728355

subject_name: Souvenaid

object_name: Mental deterioration


subject: MESH:C000728355

object_name: Cognitive impairment


subject: UMLS:C5829005


subject: UMLS:C5829005


subject: CHEBI:3515

subject_name: Cefuroxime

object_name: osteoarthritis, knee


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:81567

subject_name: Thyrotropin

object_name: differentiated thyroid carcinoma


subject: UMLS:C0876183

subject_name: Thyrogen


subject: UMLS:C4053647

object_name: bipolar I disorder


subject: PUBCHEM.COMPOUND:22064497

subject_name: Elagolix

object_name: endometriosis


subject: PUBCHEM.COMPOUND:541197

subject_name: Norethindrone acetate


subject: CHEBI:7627

subject_name: Norethisterone


subject: PR:000015454

subject_name: sperm-associated antigen 11B


subject: PR:000022039

subject_name: dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex


subject: PR:000015453

subject_name: sperm-associated antigen 11A


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: Neck Carcinoma


subject: UNII:M487QF2F4V

object_name: head and neck neoplasm


subject: UNII:M487QF2F4V

object_name: head and neck cancer


subject: UMLS:C1321603

subject_name: INJECTION, AMIFOSTINE, 500 MG ADMINISTERED


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:91594


subject: CHEBI:91594


subject: CHEBI:91594


subject: UMLS:C0678133

subject_name: Taxol


subject: UMLS:C0678133


subject: UMLS:C0678133


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: MESH:C000632500

subject_name: reolysin

object_name: non-small cell lung carcinoma


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Inflammation


subject: CHEBI:701

subject_name: licarbazepine


subject: UMLS:C1567854

subject_name: Licarbazepine


subject: CHEBI:6935

subject_name: Miglitol

object_name: type 1 diabetes mellitus 1


subject: CHEBI:6935

object_name: type 1 diabetes mellitus


subject: UNII:DEW6X41BEK

subject_name: Tildrakizumab

object_name: psoriasis


subject: CHEMBL.COMPOUND:CHEMBL4297692

object_name: respiratory syncytial virus infectious disease


subject: UMLS:C4744541

subject_name: gontivimab


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Recurrent Childhood Spinal Cord Neoplasm


subject: UMLS:C0919079

object_name: Recurrent Childhood Brain Stem Glioma


subject: UMLS:C0919079

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: UMLS:C0919079

object_name: childhood central nervous system mixed germ cell tumor


subject: UMLS:C0919079

object_name: Recurrent Childhood Central Nervous System Embryonal Tumor


subject: UMLS:C0919079

object_name: Recurrent Childhood Subependymal Giant Cell Astrocytoma


subject: UMLS:C0919079

object_name: recurrent childhood visual pathway and hypothalamic glioma


subject: UMLS:C0919079

object_name: Childhood Atypical Teratoid/Rhabdoid Tumor


subject: UMLS:C0919079

object_name: Childhood Central Nervous System Embryonal Neoplasm


subject: UMLS:C0919079

object_name: childhood central nervous system primitive neuroectodermal neoplasm


subject: UMLS:C0919079

object_name: central nervous system endodermal sinus tumor


subject: UMLS:C0919079

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: UMLS:C0919079

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: UMLS:C0919079

object_name: Recurrent Childhood Medulloblastoma


subject: UMLS:C0919079

object_name: childhood choroid plexus neoplasm


subject: UMLS:C0919079

object_name: Recurrent Childhood Ependymoma


subject: UMLS:C0919079

object_name: Recurrent Childhood Pineoblastoma


subject: UMLS:C0919079

object_name: pediatric infratentorial ependymoma


subject: UMLS:C0919079

object_name: pediatric CNS choriocarcinoma


subject: UMLS:C0919079

object_name: childhood high-grade cerebellar astrocytoma


subject: UMLS:C0919079

object_name: pediatric supratentorial ependymoma


subject: UMLS:C0919079

object_name: childhood low-grade cerebellar astrocytoma


subject: UMLS:C0919079

object_name: childhood low-grade cerebral astrocytoma


subject: UMLS:C0919079

object_name: childhood central nervous system germinoma


subject: UMLS:C0919079

object_name: Childhood Central Nervous System Teratoma


subject: UMLS:C0919079

object_name: Childhood Grade I Meningioma


subject: UMLS:C0919079

object_name: Childhood Grade III Meningioma


subject: UMLS:C0919079

object_name: Childhood Grade II Meningioma


subject: UMLS:C0919079

object_name: childhood medulloepithelioma


subject: UMLS:C0919079

object_name: Childhood Craniopharyngioma


subject: UMLS:C0919079

object_name: pediatric cerebral ependymoblastoma


subject: UMLS:C0919079

object_name: Malignant Paraganglioma


subject: UMLS:C0919079

object_name: paragangliomas 1


subject: UMLS:C0919079

object_name: Childhood Mixed Glioma


subject: CHEBI:72564

subject_name: Temozolomide

object_name: Recurrent Childhood Spinal Cord Neoplasm


subject: CHEBI:72564

object_name: Recurrent Childhood Brain Stem Glioma


subject: CHEBI:72564

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: CHEBI:72564

object_name: childhood central nervous system mixed germ cell tumor


subject: CHEBI:72564

object_name: Recurrent Childhood Central Nervous System Embryonal Tumor


subject: CHEBI:72564

object_name: Recurrent Childhood Subependymal Giant Cell Astrocytoma


subject: CHEBI:72564

object_name: recurrent childhood visual pathway and hypothalamic glioma


subject: CHEBI:72564

object_name: Childhood Atypical Teratoid/Rhabdoid Tumor


subject: CHEBI:72564

object_name: Childhood Central Nervous System Embryonal Neoplasm


subject: CHEBI:72564

object_name: childhood central nervous system primitive neuroectodermal neoplasm


subject: CHEBI:72564

object_name: central nervous system endodermal sinus tumor


subject: CHEBI:72564

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: CHEBI:72564

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: CHEBI:72564

object_name: Recurrent Childhood Medulloblastoma


subject: CHEBI:72564

object_name: childhood choroid plexus neoplasm


subject: CHEBI:72564

object_name: Recurrent Childhood Ependymoma


subject: CHEBI:72564

object_name: Recurrent Childhood Pineoblastoma


subject: CHEBI:72564

object_name: pediatric infratentorial ependymoma


subject: CHEBI:72564

object_name: pediatric CNS choriocarcinoma


subject: CHEBI:72564

object_name: childhood high-grade cerebellar astrocytoma


subject: CHEBI:72564

object_name: pediatric supratentorial ependymoma


subject: CHEBI:72564

object_name: childhood low-grade cerebellar astrocytoma


subject: CHEBI:72564

object_name: childhood low-grade cerebral astrocytoma


subject: CHEBI:72564

object_name: childhood central nervous system germinoma


subject: CHEBI:72564

object_name: Childhood Central Nervous System Teratoma


subject: CHEBI:72564

object_name: Childhood Grade I Meningioma


subject: CHEBI:72564

object_name: Childhood Grade III Meningioma


subject: CHEBI:72564

object_name: Childhood Grade II Meningioma


subject: CHEBI:72564

object_name: childhood medulloepithelioma


subject: CHEBI:72564

object_name: Childhood Craniopharyngioma


subject: CHEBI:72564

object_name: pediatric cerebral ependymoblastoma


subject: CHEBI:72564

object_name: Malignant Paraganglioma


subject: CHEBI:72564

object_name: paragangliomas 1


subject: CHEBI:72564

object_name: Childhood Mixed Glioma


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Recurrent Childhood Spinal Cord Neoplasm


subject: CHEBI:45716

object_name: Recurrent Childhood Brain Stem Glioma


subject: CHEBI:45716

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: CHEBI:45716

object_name: childhood central nervous system mixed germ cell tumor


subject: CHEBI:45716

object_name: Recurrent Childhood Central Nervous System Embryonal Tumor


subject: CHEBI:45716

object_name: Recurrent Childhood Subependymal Giant Cell Astrocytoma


subject: CHEBI:45716

object_name: recurrent childhood visual pathway and hypothalamic glioma


subject: CHEBI:45716

object_name: Childhood Atypical Teratoid/Rhabdoid Tumor


subject: CHEBI:45716

object_name: Childhood Central Nervous System Embryonal Neoplasm


subject: CHEBI:45716

object_name: childhood central nervous system primitive neuroectodermal neoplasm


subject: CHEBI:45716

object_name: central nervous system endodermal sinus tumor


subject: CHEBI:45716

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: CHEBI:45716

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: CHEBI:45716

object_name: Recurrent Childhood Medulloblastoma


subject: CHEBI:45716

object_name: childhood choroid plexus neoplasm


subject: CHEBI:45716

object_name: Recurrent Childhood Ependymoma


subject: CHEBI:45716

object_name: Recurrent Childhood Pineoblastoma


subject: CHEBI:45716

object_name: pediatric infratentorial ependymoma


subject: CHEBI:45716

object_name: pediatric CNS choriocarcinoma


subject: CHEBI:45716

object_name: childhood high-grade cerebellar astrocytoma


subject: CHEBI:45716

object_name: pediatric supratentorial ependymoma


subject: CHEBI:45716

object_name: childhood low-grade cerebellar astrocytoma


subject: CHEBI:45716

object_name: Childhood Glioblastoma


subject: CHEBI:45716

object_name: childhood low-grade cerebral astrocytoma


subject: CHEBI:45716

object_name: childhood central nervous system germinoma


subject: CHEBI:45716

object_name: Childhood Central Nervous System Teratoma


subject: CHEBI:45716

object_name: Childhood Grade I Meningioma


subject: CHEBI:45716

object_name: Childhood Grade III Meningioma


subject: CHEBI:45716

object_name: Childhood Grade II Meningioma


subject: CHEBI:45716

object_name: childhood medulloepithelioma


subject: CHEBI:45716

object_name: Childhood Craniopharyngioma


subject: CHEBI:45716

object_name: childhood oligodendroglioma


subject: CHEBI:45716

object_name: pediatric cerebral ependymoblastoma


subject: CHEBI:45716

object_name: Malignant Paraganglioma


subject: CHEBI:45716

object_name: paragangliomas 1


subject: CHEBI:45716

object_name: Childhood Mixed Glioma


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: pain agnosia


subject: CHEBI:46195

object_name: Pain insensitivity


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: UMLS:C3852624

object_name: non-small cell lung carcinoma


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: iron deficiency anemia


subject: CHEBI:75832

object_name: inflammatory bowel disease


subject: PUBCHEM.COMPOUND:46874763

object_name: Infection


subject: PUBCHEM.COMPOUND:46874763

object_name: infectious disease


subject: PUBCHEM.COMPOUND:46874763

object_name: Adverse Event Associated with Infection


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: CHEBI:3374

subject_name: Capsaicin

object_name: Chest pain


subject: PUBCHEM.COMPOUND:57928403

subject_name: peficitinib

object_name: psoriasis


subject: UNII:HPH1166CKX

subject_name: Peficitinib


subject: CHEBI:9468

subject_name: Tetracaine

object_name: Local anaesthetics causing adverse effects in therapeutic use


subject: CHEBI:9468

object_name: Infiltration


subject: CHEBI:9468

object_name: dental pulp disorder


subject: CHEBI:7862

subject_name: Oxymetazoline


subject: CHEBI:7862


subject: CHEBI:7862


subject: UNII:2GFP9BJD79

subject_name: Glucarpidase

object_name: pediatric osteosarcoma


subject: UNII:2GFP9BJD79

object_name: Osteosarcoma


subject: CHEBI:55340

subject_name: morphine hydrochloride

object_name: Surgical procedure finding


subject: CHEBI:55340

object_name: no feeling or sensation of skin


subject: CHEBI:55340

object_name: Sensory Loss


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Restless legs


subject: CHEBI:64356

subject_name: Pregabalin


subject: UMLS:C5447482

subject_name: Ligufalimab

object_name: Hodgkin Disease


subject: UMLS:C5854382

subject_name: Anti-PD-1/LAG-3 Bispecific Antibody AK129


subject: CHEMBL.COMPOUND:CHEMBL4298095

subject_name: NIMACIMAB

object_name: Gastroparesis due to diabetes mellitus


subject: UMLS:C5139907

subject_name: Nimacimab


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: Nasal Polyp


subject: PUBCHEM.COMPOUND:11360300

subject_name: TRELAGLIPTIN

object_name: type 2 diabetes mellitus


subject: CHEBI:8107

subject_name: Phenytoin

object_name: optic neuritis


subject: CHEBI:8107

object_name: multiple sclerosis


subject: UMLS:C4733680

subject_name: Autologous B-cell/Monocyte-presenting HER2/neu Antigen Vaccine BVAC-B

object_name: gastric neoplasm


subject: UMLS:C2347570

object_name: triple-negative breast carcinoma


subject: UMLS:C2347570

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:134736

subject_name: Vintafolide

object_name: endometrial cancer


subject: CHEBI:134736

object_name: uterine corpus cancer


subject: CHEBI:134736

object_name: endometrial carcinoma


subject: CHEBI:134736

object_name: ovarian cancer


subject: CHEBI:134736

object_name: ovarian neoplasm


subject: CHEBI:134736

object_name: ovarian carcinoma


subject: CHEBI:94807

subject_name: Nitazoxanide


subject: CHEBI:72296

subject_name: Apixaban

object_name: atrial septal defect, ostium secundum type


subject: CHEBI:72296

object_name: patent foramen ovale


subject: CHEBI:31859

subject_name: Modafinil

object_name: narcolepsy


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Childhood Solid Neoplasm


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367

object_name: cancer


subject: PUBCHEM.COMPOUND:3367

object_name: neoplasm


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: Solid Neoplasm


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin


subject: UNII:M89N0Q7EQR


subject: MESH:C487365

subject_name: Neodolpasse

object_name: Post-Operative Pain


subject: MESH:C487365

object_name: Rupture of cruciate ligaments


subject: MESH:C487365

object_name: Analgesic adverse reaction


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: lung cancer


subject: CHEBI:141969

object_name: lung neoplasm


subject: CHEBI:141969

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:163373364


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Partial Seizure


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:2569

subject_name: Alfentanil

object_name: Blood Pressure Finding


subject: CHEBI:2569

object_name: Systemic arterial pressure


subject: UMLS:C4329233

subject_name: AXL Receptor Tyrosine Kinase/cMET Inhibitor BPI-9016M

object_name: non-small cell lung carcinoma


subject: UMLS:C3540798

subject_name: Food allergenic extracts

object_name: Chemotherapy-induced nausea and vomiting


subject: CHEBI:64321

subject_name: Fosaprepitant


subject: UNII:305EB53128

subject_name: Dotinurad

object_name: hypertension


subject: UNII:305EB53128

object_name: Hypertension, CTCAE


subject: CHEBI:24848

subject_name: inositol

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:24848

object_name: metabolic syndrome X


subject: CHEBI:24848

object_name: Myocardial fibrosis


subject: UMLS:C3892970

subject_name: Toujeo

object_name: type 2 diabetes mellitus


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: Disorder caused by ureteric stent


subject: CHEBI:135530

subject_name: Solifenacin


subject: CHEBI:6121

subject_name: Ketamine

object_name: treatment resistant depression


subject: CHEBI:6121


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: Carcinoma breast stage IV


subject: UNII:0K5743G68X

subject_name: Lemborexant

object_name: Presenile dementia


subject: UNII:0K5743G68X

object_name: dementia


subject: UNII:0K5743G68X

object_name: Pick Complex


subject: UNII:0K5743G68X

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UNII:0K5743G68X

object_name: frontotemporal dementia


subject: UNII:0K5743G68X

object_name: Pick disease


subject: HMDB:HMDB0015332

subject_name: Rifapentine

object_name: kidney failure


subject: CHEBI:135117

subject_name: ftivazide

object_name: latent tuberculosis infection


subject: CHEBI:135117


subject: CHEBI:6030

subject_name: Isoniazid


subject: CHEBI:6030


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: CHEBI:58097

object_name: Multiple rib fractures


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:64356

subject_name: Pregabalin


subject: UNII:LIA7Z4002P

subject_name: Nadroparin

object_name: Blood Clot


subject: UNII:LIA7Z4002P

object_name: thrombosis


subject: UNII:LIA7Z4002P

object_name: Thrombosis of blood vessel


subject: UNII:LIA7Z4002P

object_name: Thromboembolism


subject: UNII:LIA7Z4002P

object_name: pulmonary embolism


subject: UNII:LIA7Z4002P

object_name: aneurysm


subject: UNII:C6RWP0N0L2

subject_name: Silmitasertib

object_name: Coronavinae infectious disease


subject: CHEBI:232617


subject: UMLS:C2351194

object_name: hypertriglyceridemia


subject: UMLS:C2351194

object_name: Hypertriglyceridemia, CTCAE


subject: UMLS:C2351194

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C2351194


subject: UMLS:C2351194

object_name: Hypercholesterolemia


subject: CHEBI:23965

subject_name: estradiol

object_name: Pain in female genitalia on intercourse


subject: CHEBI:23965

object_name: Dyspareunia


subject: CHEBI:23965

object_name: Dyspareunia, CTCAE


subject: CHEBI:23965

object_name: Painful intercourse female


subject: UMLS:C3642376

object_name: cancer


subject: CHEBI:49603

subject_name: Lapatinib

object_name: prostate carcinoma


subject: CHEBI:49603

object_name: prostate cancer


subject: UNII:T8AG54E3CT

subject_name: GBS-NN

object_name: group B streptococcal infection


subject: CHEBI:8499

subject_name: Propranolol

object_name: hypotension


subject: CHEBI:8499

object_name: Hypotension, CTCAE


subject: CHEBI:71940

subject_name: Tadalafil

object_name: coronary microvascular disorder


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: castration-resistant prostate carcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:165874


subject: UNII:897NVD4A52

subject_name: p-Chloroamphetamine


subject: CHEBI:62248


subject: CHEBI:36751


subject: CHEBI:16010


subject: UMLS:C0034330

subject_name: Pidolic acid


subject: CHEBI:40279

subject_name: Allopurinol

object_name: gout


subject: CHEBI:231425

subject_name: tolvaptan

object_name: Hyponatremia


subject: CHEBI:231425

object_name: Water-Electrolyte Imbalance


subject: CHEBI:231425

object_name: water intoxication


subject: CHEBI:231425

object_name: inappropriate ADH syndrome


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: rectal carcinoma


subject: GTOPDB:9758

object_name: rectal cancer


subject: GTOPDB:9758

object_name: Childhood Rectal Carcinoma


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: CHEBI:131752

subject_name: (R)-iclaprim

object_name: peanut allergy


subject: UNII:420K487FSG

subject_name: Dupilumab


subject: UMLS:C3658854


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: Raynaud disease


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: interstitial lung disease 1


subject: CHEBI:3770

object_name: interstitial lung disease 2


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: PUBCHEM.COMPOUND:18762634

subject_name: Avanafil

object_name: urinary system disorder


subject: UMLS:C5962479

subject_name: Anti-PD-1 Antibody-IL-15/IL-15Ra Fusion Protein IAP0971

object_name: Advanced cancer


subject: CHEBI:9555

subject_name: Tioguanine

object_name: acute lymphoblastic leukemia


subject: CHEBI:32660

subject_name: asparaginase


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: PR:000010755


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: PUBCHEM.COMPOUND:2154

subject_name: Aminopterin


subject: UMLS:C4287792

object_name: cervical cancer


subject: UMLS:C4287792

object_name: cervical carcinoma


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UNII:55VNK5440P

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C1328147

subject_name: Pivanex


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168

object_name: interstitial lung disease


subject: UMLS:C1614132

subject_name: Zmax

object_name: otitis media


subject: UMLS:C1614132

object_name: infectious otitis media


subject: UMLS:C1614132

object_name: Otitis Media, CTCAE


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:2955


subject: UMLS:C5448020

subject_name: EGFR Inhibitor TY-9591

object_name: non-small cell lung carcinoma


subject: UMLS:C5448020

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C5448020

object_name: Activating EGFR Gene Mutation


subject: MESH:C549376

subject_name: Xuebijing

object_name: COPD, severe early onset


subject: MESH:C549376

object_name: chronic obstructive pulmonary disease


subject: UNII:1B8447E7YI

subject_name: CLOMIPHENE CITRATE

object_name: Asymptomatic Diseases


subject: CHEBI:3752

subject_name: Clomifene


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: biliary tract neoplasm


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:32188

subject_name: Tegafur


subject: UMLS:C5418093

object_name: ovarian cancer


subject: UMLS:C5418093

object_name: ovarian neoplasm


subject: UMLS:C5418093

object_name: ovarian carcinoma


subject: UNII:J43DL56H6M

subject_name: foralumab

object_name: secondary progressive multiple sclerosis


subject: UMLS:C2987422


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Melanoma recurrent


subject: UNII:5TAA004E22

object_name: uveal melanoma


subject: UNII:5TAA004E22

object_name: iris melanoma


subject: UNII:5TAA004E22

object_name: Recurrent Uveal Melanoma


subject: UNII:5TAA004E22

object_name: mucosal melanoma


subject: UNII:5TAA004E22

object_name: Stage IV Uveal Melanoma AJCC v7


subject: UNII:5TAA004E22

object_name: Stage IIIA Uveal Melanoma AJCC v7


subject: UNII:5TAA004E22

object_name: Stage IIIC Uveal Melanoma AJCC v7


subject: UNII:5TAA004E22

object_name: Stage IIIB Uveal Melanoma AJCC v7


subject: UNII:5TAA004E22

object_name: Stage IIA Uveal Melanoma AJCC v7


subject: UNII:5TAA004E22

object_name: Stage IIB Uveal Melanoma AJCC v7


subject: UNII:5TAA004E22

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: UNII:5TAA004E22

object_name: Stage IIIA Cutaneous Melanoma AJCC v7


subject: UNII:5TAA004E22

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: UNII:5TAA004E22

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UNII:5TAA004E22

object_name: Stage IIB Cutaneous Melanoma AJCC v6 and v7


subject: UNII:5TAA004E22

object_name: Stage IIC Cutaneous Melanoma AJCC v6 and v7


subject: UNII:5TAA004E22

object_name: Stage IIA Cutaneous Melanoma AJCC v6 and v7


subject: UNII:5TAA004E22

object_name: ocular melanoma with extraocular extension


subject: UNII:5TAA004E22

object_name: posterior uveal melanoma


subject: UNII:5TAA004E22

object_name: small size posterior uveal melanoma


subject: UNII:5TAA004E22

object_name: medium/large size posterior uveal melanoma


subject: PR:000005931

object_name: Melanoma recurrent


subject: PR:000005931

object_name: uveal melanoma


subject: PR:000005931

object_name: iris melanoma


subject: PR:000005931

object_name: Recurrent Uveal Melanoma


subject: PR:000005931

object_name: mucosal melanoma


subject: PR:000005931

object_name: Stage IV Uveal Melanoma AJCC v7


subject: PR:000005931

object_name: Stage IIIA Uveal Melanoma AJCC v7


subject: PR:000005931

object_name: Stage IIIC Uveal Melanoma AJCC v7


subject: PR:000005931

object_name: Stage IIIB Uveal Melanoma AJCC v7


subject: PR:000005931

object_name: Stage IIA Uveal Melanoma AJCC v7


subject: PR:000005931

object_name: Stage IIB Uveal Melanoma AJCC v7


subject: PR:000005931

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: PR:000005931

object_name: Stage IIIA Cutaneous Melanoma AJCC v7


subject: PR:000005931

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: PR:000005931

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: PR:000005931

object_name: Stage IIB Cutaneous Melanoma AJCC v6 and v7


subject: PR:000005931

object_name: Stage IIC Cutaneous Melanoma AJCC v6 and v7


subject: PR:000005931

object_name: Stage IIA Cutaneous Melanoma AJCC v6 and v7


subject: PR:000005931

object_name: ocular melanoma with extraocular extension


subject: PR:000005931

object_name: posterior uveal melanoma


subject: PR:000005931

object_name: small size posterior uveal melanoma


subject: PR:000005931

object_name: medium/large size posterior uveal melanoma


subject: UMLS:C0338254

subject_name: tyrosinase peptide

object_name: Melanoma recurrent


subject: UMLS:C0338254

object_name: uveal melanoma


subject: UMLS:C0338254

object_name: iris melanoma


subject: UMLS:C0338254

object_name: Recurrent Uveal Melanoma


subject: UMLS:C0338254

object_name: mucosal melanoma


subject: UMLS:C0338254

object_name: Stage IV Uveal Melanoma AJCC v7


subject: UMLS:C0338254

object_name: Stage IIIA Uveal Melanoma AJCC v7


subject: UMLS:C0338254

object_name: Stage IIIC Uveal Melanoma AJCC v7


subject: UMLS:C0338254

object_name: Stage IIIB Uveal Melanoma AJCC v7


subject: UMLS:C0338254

object_name: Stage IIA Uveal Melanoma AJCC v7


subject: UMLS:C0338254

object_name: Stage IIB Uveal Melanoma AJCC v7


subject: UMLS:C0338254

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: UMLS:C0338254

object_name: Stage IIIA Cutaneous Melanoma AJCC v7


subject: UMLS:C0338254

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: UMLS:C0338254

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C0338254

object_name: Stage IIB Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C0338254

object_name: Stage IIC Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C0338254

object_name: Stage IIA Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C0338254

object_name: ocular melanoma with extraocular extension


subject: UMLS:C0338254

object_name: posterior uveal melanoma


subject: UMLS:C0338254

object_name: small size posterior uveal melanoma


subject: UMLS:C0338254

object_name: medium/large size posterior uveal melanoma


subject: UMLS:C5435096

object_name: celiac disease


subject: UMLS:C5435096

object_name: metabolic disease


subject: UMLS:C5435096

object_name: intestinal disorder


subject: UMLS:C5435096

object_name: digestive system disorder


subject: UMLS:C5435096

object_name: gastrointestinal disease


subject: UMLS:C5435096

object_name: Gluten intolerance


subject: UMLS:C5435096

object_name: History of gluten sensitivity


subject: UMLS:C5435096

object_name: malabsorption syndrome


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: Melanoma recurrent


subject: UNII:QEN1X95CIX

object_name: Metastatic Cutaneous Melanoma


subject: UNII:QEN1X95CIX

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UNII:QEN1X95CIX

object_name: metastatic melanoma


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab

object_name: non-small cell lung carcinoma


subject: UMLS:C1721684

subject_name: lexatumumab


subject: CHEMBL.COMPOUND:CHEMBL5095362

subject_name: VOLRUSTOMIG


subject: UMLS:C5417881

subject_name: Volrustomig


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: Recurrent Endometrial Cancer


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Fallopian Tube Carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Primary Peritoneal Carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:135565596

object_name: endometrium adenocarcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Primary Peritoneal High Grade Serous Adenocarcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Platinum-Resistant Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: high grade ovarian serous adenocarcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Deleterious BRCA1 Gene Mutation


subject: PUBCHEM.COMPOUND:135565596

object_name: Deleterious BRCA2 Gene Mutation


subject: PUBCHEM.COMPOUND:135565596

object_name: Progressive cGVHD


subject: PUBCHEM.COMPOUND:135565596

object_name: Progressive Disease


subject: PUBCHEM.COMPOUND:135565596

object_name: Progressive Neoplastic Disease


subject: PUBCHEM.COMPOUND:135565596

object_name: IMWG Progressive Disease


subject: PUBCHEM.COMPOUND:135565596

object_name: irPD (Immune-Related Response Criteria)


subject: PUBCHEM.COMPOUND:135565596

object_name: Global Progressive Disease in Viscera


subject: PUBCHEM.COMPOUND:135565596

object_name: RECIL PD


subject: PUBCHEM.COMPOUND:135565596

object_name: Global Progressive Disease in Skin


subject: PUBCHEM.COMPOUND:135565596

object_name: Global Progressive Disease


subject: PUBCHEM.COMPOUND:135565596

object_name: Global Progressive Disease in Lymph Nodes


subject: PUBCHEM.COMPOUND:135565596

object_name: Global Progressive Disease in Blood


subject: CHEBI:173077

object_name: Recurrent Endometrial Cancer


subject: CHEBI:173077

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:173077

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:173077

object_name: Recurrent ovarian cancer


subject: CHEBI:173077

object_name: endometrium adenocarcinoma


subject: CHEBI:173077

object_name: Primary Peritoneal High Grade Serous Adenocarcinoma


subject: CHEBI:173077

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:173077

object_name: high grade ovarian serous adenocarcinoma


subject: CHEBI:173077

object_name: Deleterious BRCA1 Gene Mutation


subject: CHEBI:173077

object_name: Deleterious BRCA2 Gene Mutation


subject: CHEBI:173077

object_name: Progressive cGVHD


subject: CHEBI:173077

object_name: Progressive Disease


subject: CHEBI:173077

object_name: Progressive Neoplastic Disease


subject: CHEBI:173077

object_name: IMWG Progressive Disease


subject: CHEBI:173077

object_name: irPD (Immune-Related Response Criteria)


subject: CHEBI:173077

object_name: Global Progressive Disease in Viscera


subject: CHEBI:173077

object_name: RECIL PD


subject: CHEBI:173077

object_name: Global Progressive Disease in Skin


subject: CHEBI:173077

object_name: Global Progressive Disease


subject: CHEBI:173077

object_name: Global Progressive Disease in Lymph Nodes


subject: CHEBI:173077

object_name: Global Progressive Disease in Blood


subject: CHEBI:177298

object_name: Recurrent Endometrial Cancer


subject: CHEBI:177298

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:177298

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:177298

object_name: Recurrent ovarian cancer


subject: CHEBI:177298

object_name: endometrium adenocarcinoma


subject: CHEBI:177298

object_name: Primary Peritoneal High Grade Serous Adenocarcinoma


subject: CHEBI:177298

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:177298

object_name: high grade ovarian serous adenocarcinoma


subject: CHEBI:177298

object_name: Deleterious BRCA1 Gene Mutation


subject: CHEBI:177298

object_name: Deleterious BRCA2 Gene Mutation


subject: CHEBI:177298

object_name: Progressive cGVHD


subject: CHEBI:177298

object_name: Progressive Disease


subject: CHEBI:177298

object_name: Progressive Neoplastic Disease


subject: CHEBI:177298

object_name: IMWG Progressive Disease


subject: CHEBI:177298

object_name: irPD (Immune-Related Response Criteria)


subject: CHEBI:177298

object_name: Global Progressive Disease in Viscera


subject: CHEBI:177298

object_name: RECIL PD


subject: CHEBI:177298

object_name: Global Progressive Disease in Skin


subject: CHEBI:177298

object_name: Global Progressive Disease


subject: CHEBI:177298

object_name: Global Progressive Disease in Lymph Nodes


subject: CHEBI:177298

object_name: Global Progressive Disease in Blood


subject: CHEBI:176844

subject_name: Niraparib

object_name: Recurrent Endometrial Cancer


subject: CHEBI:176844

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:176844

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:176844

object_name: Recurrent ovarian cancer


subject: CHEBI:176844

object_name: endometrium adenocarcinoma


subject: CHEBI:176844

object_name: Primary Peritoneal High Grade Serous Adenocarcinoma


subject: CHEBI:176844

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:176844

object_name: high grade ovarian serous adenocarcinoma


subject: CHEBI:176844

object_name: Deleterious BRCA1 Gene Mutation


subject: CHEBI:176844

object_name: Deleterious BRCA2 Gene Mutation


subject: CHEBI:176844

object_name: Progressive cGVHD


subject: CHEBI:176844

object_name: Progressive Disease


subject: CHEBI:176844

object_name: Progressive Neoplastic Disease


subject: CHEBI:176844

object_name: IMWG Progressive Disease


subject: CHEBI:176844

object_name: irPD (Immune-Related Response Criteria)


subject: CHEBI:176844

object_name: Global Progressive Disease in Viscera


subject: CHEBI:176844

object_name: RECIL PD


subject: CHEBI:176844

object_name: Global Progressive Disease in Skin


subject: CHEBI:176844

object_name: Global Progressive Disease


subject: CHEBI:176844

object_name: Global Progressive Disease in Lymph Nodes


subject: CHEBI:176844

object_name: Global Progressive Disease in Blood


subject: UMLS:C1831916

subject_name: Aczone Gel

object_name: acne


subject: CHEBI:6775

subject_name: Mesalazine

object_name: diarrhea


subject: CHEBI:6775

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:6775

object_name: Diarrhea, CTCAE


subject: CHEBI:6775

object_name: immune-mediated adverse reaction


subject: CHEBI:6775

object_name: Advanced Rectal Carcinoma


subject: CHEBI:6775

object_name: Advanced Melanoma


subject: CHEBI:231342

subject_name: ceralasertib

object_name: breast neoplasm


subject: CHEBI:231342

object_name: Homologous Recombination Deficiency


subject: CHEBI:231342


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:2569

subject_name: Alfentanil

object_name: Emergence Delirium


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Prolonged neonatal jaundice


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:721809WQCP

subject_name: Ruboxistaurin

object_name: diabetic macular edema


subject: PUBCHEM.COMPOUND:129627881

subject_name: Noac

object_name: atrial fibrillation


subject: PUBCHEM.COMPOUND:129627881

object_name: Atrial Fibrillation by ECG Finding


subject: PUBCHEM.COMPOUND:129627881

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:231132

subject_name: N(4)-Oleylcytosine arabinoside


subject: CHEBI:231132


subject: CHEBI:231132


subject: UMLS:C5552956

subject_name: Direct Oral Anticoagulant


subject: UMLS:C5552956


subject: UMLS:C5552956


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Breast Atrophy


subject: CHEBI:28939

object_name: Graft loss


subject: CHEBI:28939

object_name: Congenital anomaly of breast


subject: CHEBI:28939

object_name: Adipose Tissue Atrophy


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:7421


subject: CHEBI:7421


subject: CHEBI:7421


subject: CHEBI:2948

subject_name: Azathioprine

object_name: liver disorder


subject: CHEBI:80345

subject_name: Cholecystokinin

object_name: Abdominal pain


subject: CHEBI:80345

object_name: Abdominal Pain, CTCAE


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: Post-Operative Pain


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:87631

subject_name: statin

object_name: inherited lipid metabolism disorder


subject: CHEBI:87631

object_name: Dyslipidemia


subject: UMLS:C1330419

subject_name: Niacin ER


subject: UMLS:C1330419


subject: CHEBI:135942

subject_name: Laropiprant


subject: CHEBI:135942


subject: PUBCHEM.COMPOUND:10216733

subject_name: DIASTEREOMER 2


subject: PUBCHEM.COMPOUND:10216733


subject: CHEBI:2038

subject_name: Azacitidine

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:133021

subject_name: Venetoclax


subject: UMLS:C3896903

subject_name: Transdermal 17beta-Estradiol Gel BHR-200

object_name: prostate carcinoma


subject: UMLS:C3896903

object_name: prostate cancer


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: osteoporosis


subject: UNII:6XC1PAD3KF

object_name: Encounter due to family history of osteoporosis


subject: UNII:6XC1PAD3KF

object_name: Osteoporosis, CTCAE 5.0


subject: UNII:6XC1PAD3KF

object_name: Osteoporosis, CTCAE 3.0


subject: UNII:6XC1PAD3KF

object_name: Myelodysplasia


subject: UNII:6XC1PAD3KF

object_name: ovarian cancer


subject: UNII:6XC1PAD3KF

object_name: ovarian neoplasm


subject: UNII:6XC1PAD3KF

object_name: ovarian carcinoma


subject: UNII:6XC1PAD3KF

object_name: leukemia


subject: UNII:6XC1PAD3KF

object_name: childhood leukemia


subject: UNII:6XC1PAD3KF

object_name: adult lymphoma


subject: UNII:6XC1PAD3KF

object_name: lymphoma


subject: UNII:6XC1PAD3KF

object_name: pediatric lymphoma


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:4875

subject_name: Etanercept

object_name: ankylosing spondylitis


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: CHEBI:94366

subject_name: itraconazole

object_name: chronic obstructive pulmonary disease


subject: UNII:616BV6U9G8

object_name: acute kidney failure


subject: UNII:616BV6U9G8

object_name: Acute Kidney Injury, CTCAE


subject: UMLS:C5198258


subject: UMLS:C5198258


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide

object_name: cancer


subject: PUBCHEM.COMPOUND:121489720

object_name: neoplasm


subject: UMLS:C4053669


subject: UMLS:C4053669


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab

object_name: multicentric Castleman disease


subject: UNII:T4H8FMA7IM

object_name: idiopathic multicentric Castleman disease


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Hunger


subject: UNII:KG6VO684Z6

subject_name: Polatuzumab vedotin

object_name: Mantle cell lymphoma refractory


subject: UNII:KG6VO684Z6

object_name: Mantle cell lymphoma recurrent


subject: UNII:KG6VO684Z6

object_name: Marginal zone lymphoma refractory


subject: UNII:KG6VO684Z6

object_name: B-cell small lymphocytic lymphoma refractory


subject: UNII:KG6VO684Z6

object_name: B-cell lymphoma refractory


subject: UNII:KG6VO684Z6

object_name: Refractory Grade 1 Follicular Lymphoma


subject: UNII:KG6VO684Z6

object_name: Refractory Grade 2 Follicular Lymphoma


subject: UNII:KG6VO684Z6

object_name: Refractory Grade 3a Follicular Lymphoma


subject: UNII:KG6VO684Z6

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:KG6VO684Z6

object_name: Marginal zone lymphoma recurrent


subject: UNII:KG6VO684Z6

object_name: B-cell lymphoma recurrent


subject: UNII:KG6VO684Z6

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UNII:KG6VO684Z6

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UNII:KG6VO684Z6

object_name: Recurrent Grade 3a Follicular Lymphoma


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728